Published by Michele Maatouk on 20th April 2026
(Sharecast News) - Eli Lilly said on Monday that it has agreed to buy Boston-based Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery, for up to $7bn in cash.
URL: http://www.digitallook.com/dl/news/story/35864693/...